Based on the lastest quarterly filings, institutions continue to be large stakeholders in Arcturus Therapeutics Ltd. (:ARCT).  The big banks are holding 13.00% of the shares while company insiders are clinging to 36.94%.  Shares of Arcturus Therapeutics Ltd. are currently valued at $9.13 with a furture target price of $18.50 according to research brokerages.  

Investors may be looking for solid stocks to add to the portfolio. Sometimes, investors may choose to go against the grain and try something that nobody else is doing. This typically comes with plenty of time and research examining those appealing stocks. Digging into the fundamentals as well as tracking technical levels can help separate the winners from the losers. Investors who are able to keep the required temperament may be able to cope with market volatility and get positioned to take advantage of any opportunity that presents itself. 

Arcturus Therapeutics Ltd. (:ARCT)’s stock has been a favorite of “smart money” aka institutions, as of late.  Institutions are currently holders of 13.00% of the shares.  On the other hand, company insiders are holding 36.94%.  Arcturus Therapeutics Ltd.’s stock price currently sits at $9.13.

Recent Performance

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, Arcturus Therapeutics Ltd. (:ARCT)’s stock was 14.78%.  Over the last week of the month, it was 12.65%, -1.35% over the last quarter, and  52.34% for the past six months.

Over the past 50 days, Arcturus Therapeutics Ltd. stock was -2.20% off of the high and 28.32% removed from the low.  Their 52-Week High and Low are noted here.  -39.93% (High), 90.90%, (Low). 

Technical analysts have little regard for the value of a company. They use historic price data to observe stock price patterns to predict the direction of that price going forward.  Analysts use common formulas and ratios to accomplish this.

Arcturus Therapeutics Ltd. (:ARCT)’s RSI (Relative Strength Index) is 72.39.  RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions.

Another important element to consider is the price target and recommendations from brokerage firm analysts.  On a consensus basis the Street sees the stock heading to 18.50 in the near term.  Based on a 1 to 5 integer scale, analysts have a 1.70 recommendation on the name.

Investors may be getting ready to buy into the stock market as we cruise into the second half of the year. Filtering out the constant noise in the markets can be challenging. Sifting through all the data can be trying, especially for the novice investor. Digging down into the fundamentals may help weed out the undesirable companies. Investors will most likely be scouting out the equity market for any bargains. Although they may be harder to find these days, there still may be a hidden gem out there somewhere. As companies start to report quarterly earnings, investors will be closely following to see which ones are poised for success over the next few quarters. 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.